AI Portfolio Summary
In 2025 Q4, TCG Crossover Management, LLC maintained a portfolio of 48 distinct positions. The most significant new addition to the portfolio was MONTE ROSA THERAPEUT, which now represents 2.40% of the total fund value. They heavily accumulated shares in TANGO THERAPEUTICS I, increasing their position by 49.5%. Conversely, TCG Crossover Management, LLC completely exited their position in TOURMALINE BIO INC.
Total Positions
48
Quarter
2025 Q4
Top Holding
ABVX (31.7%)
Top 10 Concentration
64.3%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 48
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ABVX
ABIVAX SA AMERI...
|
Healthcare | 31.74% | 29.70% |
#1
Prev: #1
|
10.0 | no change | no change |
P
S
|
7,111,596 | $959,034,279 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 6.90% | 4.80% |
#2
1
Prev: #3
|
2.8 | -930,000 | -13.7% |
P
S
|
5,868,162 | $208,437,114 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CGON
CG ONCOLOGY INC
|
Healthcare | 5.04% | 7.27% |
#3
1
Prev: #2
|
2.0 | no change | no change |
P
S
|
3,670,206 | $152,386,953 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 3.74% | 3.53% |
#4
2
Prev: #6
|
3.6 | 4,225,898 | 49.5% |
P
S
|
12,762,094 | $113,072,153 | 2022 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CNTA
CENTESSA PHARMA...
|
Healthcare | 3.55% | 3.74% |
#5
Prev: #5
|
3.5 | 1,150,000 | 36.7% |
P
S
|
4,286,480 | $107,204,865 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 2.99% | 2.87% |
#6
4
Prev: #10
|
1.2 | no change | no change |
P
S
|
4,615,144 | $90,272,217 | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RAPT
RAPT THERAPEUTI...
|
Healthcare | 2.89% | 2.08% |
#7
8
Prev: #15
|
3.3 | 946,133 | 57.8% |
P
S
|
2,582,408 | $87,466,159 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TYRA
TYRA BIOSCIENCE...
|
Healthcare | 2.52% | 1.99% |
#8
8
Prev: #16
|
1.0 | no change | no change |
P
S
|
2,898,103 | $76,191,128 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 2.50% | 4.17% |
#9
5
Prev: #4
|
1.0 | no change | no change |
P
S
|
6,243,812 | $75,425,249 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SVRA
SAVARA INC
|
Healthcare | 2.47% | 2.17% |
#10
4
Prev: #14
|
1.0 | no change | no change |
P
S
|
12,362,205 | $74,544,096 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GLUE
MONTE ROSA THER...
|
Healthcare | 2.40% | — |
#11
Prev: #—
|
3.0 | 4,622,151 | no change |
NEW
|
4,622,151 | $72,475,328 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OCUL
OCULAR THERAPEU...
|
Healthcare | 2.31% | 3.52% |
#12
5
Prev: #7
|
0.9 | -377,001 | -6.2% |
P
S
|
5,740,231 | $69,686,404 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 2.29% | 3.25% |
#13
5
Prev: #8
|
0.9 | no change | no change |
P
S
|
1,676,624 | $69,093,675 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EYPT
EYEPOINT PHARMA...
|
Healthcare | 2.16% | 2.50% |
#14
2
Prev: #12
|
0.9 | no change | no change |
P
S
|
3,572,335 | $65,266,560 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 2.12% | 1.46% |
#15
5
Prev: #20
|
0.9 | -142,143 | -13.4% |
P
S
|
920,857 | $64,045,604 | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 2.06% | 0.91% |
#16
11
Prev: #27
|
3.0 | 800,000 | 72.7% |
P
S
|
1,900,582 | $62,263,066 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FULC
FULCRUM THERAPE...
|
Healthcare | 1.97% | 2.38% |
#17
4
Prev: #13
|
0.8 | no change | no change |
P
S
|
5,250,000 | $59,377,500 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LQDA
LIQUIDIA TECHNO...
|
Healthcare | 1.95% | 1.91% |
#18
Prev: #18
|
0.8 | no change | no change |
P
S
|
1,710,084 | $58,980,797 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 1.73% | — |
#19
Prev: #—
|
2.7 | 4,631,317 | no change |
NEW
|
4,631,317 | $52,287,569 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 1.40% | — |
#20
Prev: #—
|
2.6 | 1,660,933 | no change |
NEW
|
1,660,933 | $42,220,917 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KOD
KODIAK SCIENCES...
|
Healthcare | 1.34% | 0.92% |
#21
5
Prev: #26
|
2.6 | 300,000 | 26.2% |
P
S
|
1,445,538 | $40,417,243 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ADCT
ADC THERAPEUTIC...
|
Healthcare | 1.33% | 0.27% |
#22
15
Prev: #37
|
2.8 | 10,000,000 | 719.3% |
P
S
|
11,390,175 | $40,207,318 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LBRX
LB PHARMACEUTIC...
|
Healthcare | 1.29% | 1.36% |
#23
1
Prev: #22
|
0.5 | -1 | -0.0% |
P
S
|
1,745,015 | $38,844,034 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XNCR
XENCOR INC
|
Healthcare | 1.24% | 1.41% |
#24
3
Prev: #21
|
0.5 | no change | no change |
P
S
|
2,452,138 | $37,542,233 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 1.15% | 1.00% |
#25
2
Prev: #23
|
0.5 | no change | no change |
P
S
|
436,473 | $34,765,074 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TRML
TOURMALINE BIO ...
|
Unknown | 0.00% | 3.09% |
Sold All 😨
(Was: #9) |
0.3 | -1,311,783 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 0.00% | 1.51% |
Sold All 😨
(Was: #19) |
0.3 | -465,257 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ATXS
ASTRIA THERAPEU...
|
Healthcare | 0.00% | 0.99% |
Sold All 😨
(Was: #24) |
0.3 | -2,761,861 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ADVM
ADVERUM BIOTECH...
|
Healthcare | 0.00% | 0.37% |
Sold All 😨
(Was: #35) |
0.3 | -1,668,174 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PEPG
PEPGEN INC
|
Healthcare | 0.00% | 0.27% |
Sold All 😨
(Was: #38) |
0.3 | -1,200,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 48 holdings